The contraindications for semaglutide include a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), known hypersensitivity to semaglutide or any product components, and for Wegovy specifically, pregnancy
The FDA has approved Wegovy for weight loss in people with and without diabetes
Results indicate that the same band pattern corresponding to the major AX-serum targets, namely, HSA and the light and heavy chains of immunoglobulins, appeared in all cases
This occurs because the medication helps regulate appetite, making people feel full sooner and reducing overall food intake
In the South, some exceptions are Kentucky, Georgia, and Tennessee, which cover Wegovy for state employees, and Mississippi and North Carolina, which provides coverage in Medicaid
That is what complete care looks like